First Time Loading...

Mesoblast Ltd
ASX:MSB

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
ASX:MSB
Watchlist
Price: 1.155 AUD 6.45% Market Closed
Updated: May 6, 2024

Mesoblast Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mesoblast Ltd
Cash from Financing Activities Peer Comparison

Comparables:
IMM
CSL
CUV
TLX
PYC

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Mesoblast Ltd
ASX:MSB
Cash from Financing Activities
$67.8m
CAGR 3-Years
-11%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Immutep Ltd
ASX:IMM
Cash from Financing Activities
AU$76m
CAGR 3-Years
15%
CAGR 5-Years
29%
CAGR 10-Years
19%
CSL Ltd
ASX:CSL
Cash from Financing Activities
-$1.6B
CAGR 3-Years
-39%
CAGR 5-Years
-25%
CAGR 10-Years
-8%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Cash from Financing Activities
-AU$2.7m
CAGR 3-Years
-22%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Cash from Financing Activities
AU$10.2m
CAGR 3-Years
-33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Cash from Financing Activities
AU$28.8m
CAGR 3-Years
-9%
CAGR 5-Years
27%
CAGR 10-Years
22%

See Also

What is Mesoblast Ltd's Cash from Financing Activities?
Cash from Financing Activities
67.8m USD

Based on the financial report for Dec 31, 2023, Mesoblast Ltd's Cash from Financing Activities amounts to 67.8m USD.

What is Mesoblast Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-5%

Over the last year, the Cash from Financing Activities growth was 102%. The average annual Cash from Financing Activities growth rates for Mesoblast Ltd have been -11% over the past three years , -5% over the past five years .